Skip to content

Effect of Ayurvedic treatment in chronic simple rhinitis

Randomized Controlled Trial To Evaluate Efficacy Of Nidigdhikadi Kwatha In Management Of Peenasa (Chronic Simple Rhinitis)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/029618
Enrollment
74
Registered
2020-12-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J310- Chronic rhinitis

Interventions

Intervention1: Nidigdhikadi Kwatha: Nidigdhikadi Kwatha, Orally 20ml,(In single dose) for 21 days Control Intervention1: Levocetirizine(5mg) with Phenylephrine (10mg): Levocetrizine 5mg in combination

Sponsors

Sane Guruji Arogya Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients fulfilling the diagnostic criteria of Peenasa(Chronic Simple Rhinitis). 2) Patients suffering from three or more the following symptoms for more than one months were selected for study.( Nasal obstruction, Nasal discharge, Headache , Swollen turbinateâ??s, Post-Nasal discharge ) 3) A patients having age group 18 to 60 years. 4) Patient willing to participate in the study. 5) Patients were recruited irrespective of sex, religion, occupation.

Exclusion criteria

Exclusion criteria: 1) Pregnant women and Children. 2) Patients with history of congenital disorder of Nose. 3) Patients suffering from gross deviation of nasal septum and associated with other nasal pathology like nasal polyp etc. 4) Patients with uncontrolled systemic diseases like Diabetes Mellitus and Hypertension. 5) Chronic simple Rhinitis associated with Hyperthyroidism, Exanthemas, Adenoidal Hyperplasia, Choanal Atresia and Nasal Tumors. 6) Patient having Angle-Closure Glaucoma and Pyloric Stenosis.

Design outcomes

Primary

MeasureTime frame
Primary outcome will be evaluation of efficacy of Nidigdhikadi Kwatha in Peenasa Vyadhi w.r.t Chronic Simple RhinitisTimepoint: The drug will be given for 21 days.The efficacy will be assessed on the basis of VAS SCALE for symptoms before and after treatment. The patients will be assessed before and after treatment. Total duration of the study will 18 months.

Secondary

MeasureTime frame
A comparison between efficacy of Nidigdhikadi Kwatha and Tab Levocetrizine 5mg in combination with Phenylephrine 10mg in Peenasa Vyadhi w.r.t Chronic Simple Rhinitis will be doneTimepoint: Total duration of study is 18 Months. Baseline assessment will be done of each patient before and after treatment. Each patient will be treated for 21days. Assessment will be done on VAS SCALE

Countries

India

Contacts

Public ContactDR PRAVIN M BHAT

Sumatibhai Shah Ayurved Mahavidyalaya

vdpravin82@gmail.com09860233173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026